Lattice Biologics Ltd LBLTF

Primary Symbol: V.LBL.H

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Reduced expenses - not

<< Previous

Bullboard Posts

Next >>

Post by nothinghereon Feb 02, 2021 6:57pm

122 Views

Post# 32453689

Reduced expenses - not

Guy said he reduced operating expenses.

Other income (expense): Interest and finance charges..

2020 (1,146,763) 2019 (447,356) Net loss and comprehensive

He actually increased expenses by almost a million dollars.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland